Similar articles

• Diltiazem cardioplegia. A balance of risk and benefit.

  Christakis GT, Fremes SE, Weisel RD, Tittley JG, Mickle DA, Ivanov J, Madonik MM, Benak AM, McLaughlin PR, Baird RJ. Christakis GT, et al. J Thorac Cardiovasc Surg. 1986 May;91(5):647-61. J Thorac Cardiovasc Surg. 1986. PMID: 3517506 Clinical Trial.
• Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion.

  Melendez FJ, Gharagozloo F, Sun SC, Benfell K, Austin RE, Shemin RJ, Cohn LH. Melendez FJ, et al. J Thorac Cardiovasc Surg. 1988 Apr;95(4):613-7. J Thorac Cardiovasc Surg. 1988. PMID: 3352294
• Preservation of myocardial functions by pentoxyphylline cardioplegia during and after cardiopulmonary bypass.

  Ulus AT, Aksöyek A, Katircioğlu SF, Gökçe P, Koç B. Ulus AT, et al. Panminerva Med. 2000 Dec;42(4):253-6. Panminerva Med. 2000. PMID: 11294087
• [Effect of nicardipine cardioplegia on A-V conduction system in coronary bypass surgery].

  Nukariya M, Hosoda Y, Kudou H, Minami S, Takazawa K, Gotou M, Satoh T, Kikuchi N, Watanabe M, Tahara M, et al. Nukariya M, et al. Kyobu Geka. 1994 Nov;47(12):997-1000. Kyobu Geka. 1994. PMID: 7990293 Clinical Trial. Japanese.
• Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass.

  Clements RT, Sodha NR, Feng J, Mieno S, Boodhwani M, Ramlawi B, Bianchi C, Sellke FW. Clements RT, et al. J Thorac Cardiovasc Surg. 2007 Dec;134(6):1461-70. doi: 10.1016/j.jtcvs.2007.06.026. J Thorac Cardiovasc Surg. 2007. PMID: 18023666